ÂÜÀòÂÒÂ×

Lili Xie is a seasoned professional with extensive experience in the biotechnology sector. As Co-Founder and Director of Cellics Therapeutics, Inc. since 2016, Lili Xie has been instrumental in advancing Cellular Nanoparticle (CNP) technology aimed at curing diseases by restoring immune balance. Additionally, Lili Xie serves as Co-Founder, CEO, and President of ARYTHA BIOSCIENCES LLC, which incubates innovative CNP technology from UC San Diego. Previous roles include serving as CFO at Pharmaco-Kinesis Corporation and holding academic positions as a Visiting Professor at the University of California San Diego and Assistant Professor at Ball State University's Miller College of Business. Lili Xie's educational background includes a PhD in Economics and a Master of Science in Mathematics from the University of Illinois Urbana-Champaign, along with a Bachelor of Arts in International Finance from Peking University.